Indaptus Therapeutics - חוב לטווח קצר של החברה INDP

The asset value of Indaptus Therapeutics (INDP) reflected in the chart demonstrates the dynamics of a company that strictly adheres to medical codes regarding biohazardous waste disposal during trials. The enterprise minimizes environmental impact by optimizing water and chemical consumption, which constitutes 0.00. The business is based on creating universal cancer treatment methods for oncology centers, aiming for a significant share of the global biotechnology sector.

This indicator aggregates the total credit obligations of Indaptus Therapeutics (INDP) with maturities of up to twelve months, capturing the operational pressure on liquidity. The stability of current short-term liabilities confirms the resilience of non-cyclical tumor immunotherapy developments against macroeconomic shocks, allowing investors to assess the efficiency of debt capital management within the context of long-term oncology project financing via this chart.